Authors:
Yokel, RA
Rhineheimer, SS
Sharma, P
Elmore, D
McNamara, PJ
Citation: Ra. Yokel et al., Entry, half-life, and desferrioxamine-accelerated clearance of brain aluminum after a single Al-26 exposure, TOXICOL SCI, 64(1), 2001, pp. 77-82
Authors:
Yokel, RA
Rhineheimer, SS
Brauer, RD
Sharma, P
Elmore, D
McNamara, PJ
Citation: Ra. Yokel et al., Aluminum bioavailability from drinking water is very low and is not appreciably influenced by stomach contents or water hardness, TOXICOLOGY, 161(1-2), 2001, pp. 93-101
Authors:
Hong, CB
Fredenburg, AM
Dickey, KM
Lovell, MA
Yokel, RA
Citation: Cb. Hong et al., Glomerular lesions in male rabbits treated with aluminium lactate: with special reference to microaneurysm formation, EXP TOX PAT, 52(2), 2000, pp. 139-143
Authors:
Yokel, RA
Fredenburg, AM
Durbin, PW
Xu, JD
Rayens, MK
Raymond, KN
Citation: Ra. Yokel et al., The hexadentate hydroxypyridinonate TREN-(Me-3,2-HOPO) is a more orally active iron chelator than its bidentate analogue, J PHARM SCI, 89(4), 2000, pp. 545-555
Authors:
Brauer, RD
Robertson, JD
Sharma, P
Yokel, RA
Citation: Rd. Brauer et al., Aluminum and phosphorus separation: application to preparation of target from brain tissue for Al-26 determination by accelerator mass spectrometry, NUCL INST B, 152(1), 1999, pp. 129-134
Authors:
Geddes, JW
Chang, NG
Ackley, DC
Soultanian, NS
McGillis, JP
Yokel, RA
Citation: Jw. Geddes et al., Postmortem elevation in extracellular glutamate in the rat hippocampus when brain temperature is maintained at physiological levels: implications forthe use of human brain autopsy tissues, BRAIN RES, 831(1-2), 1999, pp. 104-112